# FDA recall D-0925-2018

> **Sanofi-Aventis U.S. LLC** · Class II · drug recall initiated 2018-07-05.

## Product

Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00

## Reason for recall

Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0925-2018
- **Recalling firm:** Sanofi-Aventis U.S. LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2018-07-05
- **Report date:** 2018-07-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bridgewater, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0925-2018

## Citation

> AI Analytics. FDA recall D-0925-2018. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0925-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*